[{"NetIncomeLoss_3_Q3_USD":416000000.0,"LongTermLineOfCredit_0_Q3_USD":800000000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_3_Q3_USD":-60800000.0,"MarketableSecuritiesCurrent_0_Q3_USD":910300000.0,"OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_3_Q3_USD":200000.0,"OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_1_Q3_USD":0.0,"PaymentsToAcquireLongtermInvestments_3_Q3_USD":0.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":38000000.0,"TreasuryStockCommonShares_0_Q3_shares":26619216.0,"InterestPaidNet_3_Q3_USD":16600000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-4500000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_0_Q3_USD":889700000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-674700000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":3600000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q3_USD":100000.0,"TreasuryStockCommonValue_0_Q3_USD":2579200000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":200000.0,"AssetsCurrent_0_Q3_USD":1868200000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3_Q3_shares":300000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q3_shares":200000.0,"OtherNoncashIncomeExpense_3_Q3_USD":6800000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":1698800000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":73300000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":24000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":7400000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":7500000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":25900000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":3500000.0,"ProceedsFromSaleOfTradingSecuritiesHeldforinvestment_3_Q3_USD":27300000.0,"IncomeTaxesPaidNet_3_Q3_USD":62300000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":1041400000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":177100000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-2700000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":8600000.0,"Liabilities_0_Q3_USD":1128100000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":231600000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":68700000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":5400000.0,"EarningsPerShareBasic_1_Q3_USD":3.86,"EarningsPerShareBasic_3_Q3_USD":9.43,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":8600000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-2700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":44600000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":44400000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":400000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-100000.0,"AccountsReceivableNetCurrent_0_Q3_USD":152300000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":108500000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":47800000.0,"CommonStockValue_0_Q3_USD":700000.0,"RepaymentsOfLinesOfCredit_3_Q3_USD":50000000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":27900000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":2125700000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":670200000.0,"OtherAssetsNoncurrent_0_Q3_USD":165400000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":168800000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":425700000.0,"IncreaseDecreaseInInventories_3_Q3_USD":-11100000.0,"UnrecognizedTaxBenefits_0_Q3_USD":0.0,"OtherAssetsCurrent_0_Q3_USD":47500000.0,"CostsAndExpenses_3_Q3_USD":570100000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_0_Q3_USD":892500000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-23000000.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.21,"DepreciationDepletionAndAmortization_3_Q3_USD":36800000.0,"ProceedsFromLinesOfCredit_3_Q3_USD":0.0,"CostsAndExpenses_1_Q3_USD":159000000.0,"CommonStockSharesIssued_0_Q3_shares":71059151.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":30000000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":2120000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-2400000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":15700000.0,"Goodwill_0_Q3_USD":28000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":524500000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":219000000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":2400000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":3600000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":50800000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":15000000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":629500000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":19900000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":44100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":44400000.0,"MarketableSecuritiesNoncurrent_0_Q3_USD":1227500000.0,"LiabilitiesCurrent_0_Q3_USD":258900000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":0.0,"NonoperatingIncomeExpense_3_Q3_USD":-3800000.0,"NetIncomeLoss_1_Q3_USD":171200000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":736400000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":4400000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"LinesOfCreditCurrent_0_Q3_USD":0.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":9700000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":2200000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":25900000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_3_Q3_USD":4700000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":670200000.0,"InterestExpense_1_Q3_USD":4900000.0,"InterestExpense_3_Q3_USD":18700000.0,"NonoperatingIncomeExpense_1_Q3_USD":-2100000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":4700000.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-300000.0,"EarningsPerShareDiluted_1_Q3_USD":3.84,"CommonStockSharesOutstanding_0_Q3_shares":44439935.0,"Assets_0_Q3_USD":4411200000.0,"ShareBasedCompensation_3_Q3_USD":70100000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.01,"DeferredIncomeTaxAssetsNet_0_Q3_USD":255500000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"GoodwillGross_0_Q3_USD":28000000.0,"CommonStockSharesAuthorized_0_Q3_shares":245000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":1098400000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":380100000.0,"OperatingIncomeLoss_3_Q3_USD":528300000.0,"OperatingIncomeLoss_1_Q3_USD":221100000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_3_Q3_USD":0.0,"InventoryNet_0_Q3_USD":87900000.0,"InvestmentIncomeInterest_3_Q3_USD":23600000.0,"InvestmentIncomeInterest_1_Q3_USD":6400000.0,"PreferredStockValue_0_Q3_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":4411200000.0,"AssetImpairmentCharges_3_Q3_USD":5400000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":900000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-68200000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":3740400000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q3_USD":158200000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":2104500000.0,"EarningsPerShareDiluted_3_Q3_USD":9.37,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":0.0,"StockholdersEquity_0_Q3_USD":3283100000.0,"OtherLiabilitiesCurrent_0_Q3_USD":49600000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":69200000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":-12500000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":70100000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":47000000.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-1100000.0,"Ticker":"UTHR","CIK":"1082554","name":"UNITED THERAPEUTICS CORP","OfficialName":"United Therapeutics Corporation Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"8315138472.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201028"}]